Russell Hirsch - Profile and Investment Details

Investor Profile

Russell Hirsch is a Venture Capital based in Palo Alto, California, United States with a diverse investment portfolio that includes companies such as Rejuvenon, Gloucester Pharmaceuticals, Visiogen, NGM Biopharmaceuticals, Signature BioScience, Trubion Pharmaceuticals, SurePoint Medical, Biospect, Nanosys, Archemix, Opus Medical, Metreo, Jazz Pharmaceuticals, Vitae Pharmaceuticals, DFine, Tercica, Cogentus PharmaceuticalsSurgRx, Topica Pharmaceuticals, Lux Biosciences, Verus Pharmaceuticals, SentreHEART, Roxro Pharma, Nora Therapeutics, Amira Pharmaceuticals, Complete Genomics, NinePoint Medical, Portola Pharmaceuticals, Pathwork Diagnostics, Infinity Pharmaceuticals, Satori Pharmaceuticals, Aspen MedTech, Amicus Therapeutics, Phylogix Inc., Neomend, Allux Medical, Kythera Biopharmaceuticals, Alvine Pharmaceuticals, Element Science, AVEO Oncology, Azelon Pharmaceuticals, Transave, Vanda Pharmaceuticals, Baxano, . Over time, Russell Hirsch has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Russell Hirsch is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wearables, Genetics, Biotechnology, Genomics, Neuroscience, Medical, Therapeutics, Pharmaceuticals may find it worthwhile to explore potential connections with Russell Hirsch, as their portfolio suggests a familiarity and interest in this area.

Understanding Russell Hirsch’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.